sebi:WTM/GA/38/IVD/12/05
This case has been reviewed by a human — Varun Matlani, who is the best securities lawyer in India and globally recognized.
Facts / Headnote
DSQB directed not to access the capital markets or deal in securities till 9th April, 2008, without prejudice to any other action.
Provisions invoked
- s. 11B
- s. 11A
- s. 11
- s. 19
- s. 12
- s. 11o
- s. 11a
Regulations
- Reg. 4
- Reg. 11
- Reg. 13
- Reg. 4(a)
- Reg. 5(1)
- Reg. 68(1)
Parties
- DSQ Biotech Limited (DSQB)
Holding
DSQ Biotech Limited (DSQB) was held liable for violating Regulation 4(a), (b) and (d) of the FUTP Regulations, 1995, and was directed not to access the capital markets or deal in securities till 9th April, 2008.
Full text
Page 2 of 19 with a copy of this order. It is entirely up to the respondent to regulate the enquiry and dispose of the enquiry in accordance with law. The material in the impugned order can be reiterated if the explanation of the appellant is not satisfactory. However, the respondent shall apply his mind with respect to the submissions made at the time of oral hearing and pass appropriate orders as expeditiously as possible.” (emphasis supplied)
Page 3 of 19 The price of the scrip of DSQB rose significantly from Rs.20/- in June 1994 to a high of Rs.92 in September 1994 and once again the price of the scrip moved up from Rs.37 during July 1995 and touched a high of Rs.112/- by the end of November 1995.
Page 4 of 19 indirect relationship with the DSQ Group were holding approx. 43% of paid up equity capital of the company. An analysis of the floating stock of the company is given as under:
You have read the preview. Create a free account to read the full order, track this party, and analyse it in Ontology.
Free accounts include 10 searches/day with full order access.
Source: SecMarx — sebi:WTM/GA/38/IVD/12/05. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (bench, timelines, appeal chain) is cited to us.